Boon C. Goh
Experienced in Chronic B-Cell Leukemia (CBCL)

Boon C. Goh

2 Medical Dr, 
Singapore, SG 
Experienced in Chronic B-Cell Leukemia (CBCL)
2 Medical Dr, 
Singapore, SG 
OverviewLocationsClinical Research

Overview

Boon Goh practices in Singapore, Singapore. Mr. Goh is rated as an Experienced expert by MediFind in the treatment of Chronic B-Cell Leukemia (CBCL). His top areas of expertise are Nasopharyngeal Carcinoma, Breast Cancer, Non-Small Cell Lung Cancer (NSCLC), Liver Cancer, and Tissue Biopsy.

His clinical research consists of co-authoring 141 peer reviewed articles and participating in 3 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Chronic B-Cell Leukemia (CBCL).

Gender
Male

Locations

2 Medical Dr, Singapore, 117593, Singapore

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

3 Clinical Trials

Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study With Correlative Biomarkers
Nivolumab in Combination With Chemoradiation for Patients With Stage II-IVB Nasopharyngeal Carcinoma, A Phase II Study With Correlative Biomarkers
Enrollment Status: Completed
Publish Date: May 30, 2025
Intervention Type: Drug, Radiation
Study Drugs: Nivolumab, Cisplatin
Study Phase: Phase 2
Integrated Molecular Analysis of Cancer (IMAC)
Integrated Molecular Analysis of Cancer (IMAC)
Enrollment Status: Unknown
Publish Date: November 09, 2023
Intervention Type: Other
Phase II Open-label Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Systemic Therapy for Locally Advanced or Metastatic Nasopharyngeal Carcinoma (NPC)
Phase II Open-label Study Evaluating Two Loading Regimens of Sunitinib or Bevacizumab Alternating With Cisplatin and Gemcitabine as Systemic Therapy for Locally Advanced or Metastatic Nasopharyngeal Carcinoma (NPC)
Enrollment Status: Completed
Publish Date: July 22, 2019
Intervention Type: Drug
Study Phase: Phase 2
View 2 Less Clinical Trials

141 Total Publications

Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.
Sevabertinib in Advanced HER2-Mutant Non-Small-Cell Lung Cancer.
Journal: The New England journal of medicine
Published: October 17, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Goh's expertise for a condition
ConditionClose
    View All 24 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile